Caricamento...
Construction of an immune-related signature with prognostic value for colon cancer
BACKGROUND: Colon cancer is the third most common malignant tumor in the world. Although immunotherapy has been used in cancer treatment, there is still no first-line immunotherapy method for colon cancer. Therefore, it is essential to search for potential immunotherapy targets and molecular biomark...
Salvato in:
| Pubblicato in: | PeerJ |
|---|---|
| Autori principali: | , , , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
PeerJ Inc.
2021
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8106397/ https://ncbi.nlm.nih.gov/pubmed/33996273 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7717/peerj.10812 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|